
Join to view full profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Dr. Shpall is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Icahn School of Medicine at Mount SinaiFellowship, Hematology and Medical Oncology, 1983 - 1985
Icahn School of Medicine at Mount Sinai/Beth IsraelResidency, Internal Medicine, 1980 - 1983
University of Cincinnati College of MedicineClass of 1980
Certifications & Licensure
FL State Medical License 2021 - Present
AZ State Medical License 2023 - 2027
MS State Medical License 2023 - 2027
OK State Medical License 2020 - 2027
TX State Medical License 2002 - 2027
AL State Medical License 2023 - 2026
GA State Medical License 2023 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology- Join now to see all
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification ClinicStation, UT MD Anderson Cancer Center, 2013-2015
Clinical Trials
Publications & Presentations
PubMed
- Outcomes of adult patients with Li-Fraumeni syndrome and myeloid neoplasms.Jayastu Senapati, Hiam M Abdel-Salam, Vladislav D Jdanov, Sanam Loghavi, Ashley Woodson
Cancer. 2026-10-01 - The Pitfalls of Categorizing Donor Age: Arbitrary Cutoffs Fail to Predict Survival in Haploidentical HCT.Yosra M Aljawai, Denái Milton, Rohtesh S Mehta, Portia Smallbone, Jeremy Ramdial
American Journal of Hematology. 2026-10-01 - Randomized Trial of Two Fractionation Schedules of Myeloablative Busulfan with Fludarabine and Cladribine in Acute Myeloid Leukemia or Myelodysplastic Syndromes.Uday R Popat, Konstantinos Lontos, Roland Bassett, Jitesh Kawedia, Ben C Valdez
Transplantation and Cellular Therapy. 2026-10-01
Journal Articles
- The Ability of a Cytomegalovirus ELISPOT Assay to Predict Outcome of Low-Level CMV Reactivation in Hematopoietic Cell Transplant RecipientsRoy F Chemaly, Elizabeth Shpall, The Journal of Infectious Diseases
- Management Guidelines for Paediatric Patients Receiving Chimeric Antigen Receptor T Cell TherapyKris M Mahadeo, Julie C Fitzgerald, Marie E Steiner, Partow Kebriaei, Katayoun Rezvani, Ira M Cheifetz, John M Slopis, Paul L Martin, Sattva S Neelapu, Agne Tarasevici..., Nature
Abstracts/Posters
- Blinatumomab Is Well Tolerated Maintenance Therapy Following Allogeneic Hematopoietic Cell Transplantation for Acute Lymphoblastic LeukemiaElizabeth J. Shpall, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- A Randomized Study of Fludarabine-Clofarabine Vs Fludarabine Alone Combined with Busulfan and Allogeneic Hematopoietic Transplantation for AML and MDSElizabeth J. Shpall, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Third-Party BK Virus Specific Cytotoxic T Lymphocyte Therapy for Hemorrhagic Cystitis Following AllotransplantationElizabeth J. Shpall, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- Assessment and Management of Cytokine Release SyndromeASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019
- Donor NKG2C Copy Number: An Independent Predictor for CMV Reactivation after Double Cord Blood Transplantation2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Manufacture of Clinical-Grade Universal Antigen Presenting Cells (UAPC) for the Ex Vivo Expansion and Activation of Natural Killer (NK) Cells2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
AACR: Researchers Share Promising Results from MD Anderson Clinical TrialsApril 25th, 2025
Top Keywords at TCT in 'Virtual' HawaiiFebruary 16th, 2021- Genetically Enhanced, Cord-Blood Derived Immune Cells Strike B-cell CancersOctober 23rd, 2020
Grant Support
- Novel Cord Blood-Derived Cellular TherapiesUNIVERSITY OF TX MD ANDERSON CAN CTR2011–2025
- Hematopoietic Progenitor Cells - Cord BloodNational Cancer Institute2010–2012
- GOOD Manufacturing Practice (GMP) And Immune Assessment CoreNational Cancer Institute2010–2011
- Hematopoietic Progenitor CellsNational Cancer Institute2002–2007
- Hematopoietic Progenitor CellsNational Cancer Institute1993–2002
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:




